AI assistant
INSMED Inc — Director's Dealing 2025
Feb 20, 2025
30150_dirs_2025-02-20_536caaaf-702f-4683-a6c0-32cbcc358bfd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-02-18
Reporting Person: Bonstein Sara (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-18 | Common Stock | S | 17622 | $80.28 | Disposed | 119563 | Direct |
| 2025-02-18 | Common Stock | S | 700 | $81 | Disposed | 118863 | Direct |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 17,622 shares sold at prices ranging from $80.00 to $80.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 700 shares sold at prices ranging from $81.00 to $81.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.